Greenwich LifeSciences, Inc. Net Income Loss

• Greenwich LifeSciences, Inc. showed a decrease of -77.6% in Net Income Loss from 2023 to 2024.
• This data is from Greenwich LifeSciences, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
• XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2019 to 2024), Greenwich LifeSciences, Inc.'s Net Income Loss has declined by 360.9%.
• Historical annual values: Fiscal year 2024: -$15.79 million | Fiscal year 2023: -$8.89 million | Fiscal year 2022: -$7.83 million | Fiscal year 2021: -$4.57 million | Fiscal year 2020: -$1.86 million | Fiscal year 2019: -$3.43 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026